DAXOR CORP

Explore DAXOR CORP: a New York‑based health‑care equipment leader, innovating blood‑volume measurement devices and offering a promising investment with a $65.7 M market cap and 10.71 P/E.

Daxor Corporation has received FDA clearance for its next-generation Blood Volume Analyzer, a handheld device that quantifies blood volume and is expected to revolutionize fluid management in clinical settings.